Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Pharmacological inhibition of myostatin improves skeletal muscle mass and function in a mouse model of stroke.

Desgeorges MM, Devillard X, Toutain J, Castells J, Divoux D, Arnould DF, Haqq C, Bernaudin M, Durieux AC, Touzani O, Freyssenet DG.

Sci Rep. 2017 Oct 25;7(1):14000. doi: 10.1038/s41598-017-13912-0.

2.

M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma.

Leblond MM, Pérès EA, Helaine C, Gérault AN, Moulin D, Anfray C, Divoux D, Petit E, Bernaudin M, Valable S.

Oncotarget. 2017 Aug 7;8(42):72597-72612. doi: 10.18632/oncotarget.19994. eCollection 2017 Sep 22.

3.

Imaging of brain oxygenation with magnetic resonance imaging: A validation with positron emission tomography in the healthy and tumoural brain.

Valable S, Corroyer-Dulmont A, Chakhoyan A, Durand L, Toutain J, Divoux D, Barré L, MacKenzie ET, Petit E, Bernaudin M, Touzani O, Barbier EL.

J Cereb Blood Flow Metab. 2017 Jul;37(7):2584-2597. doi: 10.1177/0271678X16671965. Epub 2016 Jan 1.

4.

Carbogen-induced increases in tumor oxygenation depend on the vascular status of the tumor: A multiparametric MRI study in two rat glioblastoma models.

Chakhoyan A, Corroyer-Dulmont A, Leblond MM, Gérault A, Toutain J, Chazaviel L, Divoux D, Petit E, MacKenzie ET, Kauffmann F, Delcroix N, Bernaudin M, Touzani O, Valable S.

J Cereb Blood Flow Metab. 2017 Jun;37(6):2270-2282. doi: 10.1177/0271678X16663947. Epub 2016 Jan 1.

5.

Multimodal imaging based on MRI and PET reveals [(18)F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma.

Corroyer-Dulmont A, Pérès EA, Gérault AN, Savina A, Bouquet F, Divoux D, Toutain J, Ibazizène M, MacKenzie ET, Barré L, Bernaudin M, Petit E, Valable S.

Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):682-94. doi: 10.1007/s00259-015-3225-0. Epub 2015 Nov 5.

PMID:
26537287
6.

Molecular mechanisms of skeletal muscle atrophy in a mouse model of cerebral ischemia.

Desgeorges MM, Devillard X, Toutain J, Divoux D, Castells J, Bernaudin M, Touzani O, Freyssenet DG.

Stroke. 2015 Jun;46(6):1673-80. doi: 10.1161/STROKEAHA.114.008574. Epub 2015 May 7.

PMID:
25953371
7.

Effects of mesenchymal stem cell therapy, in association with pharmacologically active microcarriers releasing VEGF, in an ischaemic stroke model in the rat.

Quittet MS, Touzani O, Sindji L, Cayon J, Fillesoye F, Toutain J, Divoux D, Marteau L, Lecocq M, Roussel S, Montero-Menei CN, Bernaudin M.

Acta Biomater. 2015 Mar;15:77-88. doi: 10.1016/j.actbio.2014.12.017. Epub 2014 Dec 31.

PMID:
25556361
8.

Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe.

Pérès EA, Gérault AN, Valable S, Roussel S, Toutain J, Divoux D, Guillamo JS, Sanson M, Bernaudin M, Petit E.

Oncotarget. 2015 Feb 10;6(4):2101-19.

9.

Noninvasive assessment of hypoxia with 3-[18F]-fluoro-1-(2-nitro-1-imidazolyl)-2-propanol ([18F]-FMISO): a PET study in two experimental models of human glioma.

Corroyer-Dulmont A, Pérès EA, Petit E, Durand L, Marteau L, Toutain J, Divoux D, Roussel S, MacKenzie ET, Barré L, Bernaudin M, Valable S.

Biol Chem. 2013 Apr;394(4):529-39. doi: 10.1515/hsz-2012-0318.

PMID:
23399636
10.

Angiopoietin-2 is vasoprotective in the acute phase of cerebral ischemia.

Marteau L, Valable S, Divoux D, Roussel SA, Touzani O, MacKenzie ET, Bernaudin M, Petit E.

J Cereb Blood Flow Metab. 2013 Mar;33(3):389-95. doi: 10.1038/jcbfm.2012.178. Epub 2012 Dec 5.

11.

Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy.

Corroyer-Dulmont A, Pérès EA, Petit E, Guillamo JS, Varoqueaux N, Roussel S, Toutain J, Divoux D, MacKenzie ET, Delamare J, Ibazizène M, Lecocq M, Jacobs AH, Barré L, Bernaudin M, Valable S.

Neuro Oncol. 2013 Jan;15(1):41-56. doi: 10.1093/neuonc/nos260. Epub 2012 Oct 31.

12.

Maternal hypertension during pregnancy modifies the response of the immature brain to hypoxia-ischemia: sequential MRI and behavioral investigations.

Letourneur A, Freret T, Roussel S, Boulouard M, Divoux D, Toutain J, Bernaudin M, Schumann-Bard P, Bouet V, Touzani O.

Exp Neurol. 2012 Jan;233(1):264-72. doi: 10.1016/j.expneurol.2011.10.014. Epub 2011 Oct 25.

PMID:
22051176
13.

Complementary information from magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model.

Valable S, Petit E, Roussel S, Marteau L, Toutain J, Divoux D, Sobrio F, Delamare J, Barré L, Bernaudin M.

Nucl Med Biol. 2011 Aug;38(6):781-93. doi: 10.1016/j.nucmedbio.2011.01.010. Epub 2011 Apr 21.

PMID:
21843775
14.

Detection and quantification of remote microglial activation in rodent models of focal ischaemia using the TSPO radioligand CLINDE.

Arlicot N, Petit E, Katsifis A, Toutain J, Divoux D, Bodard S, Roussel S, Guilloteau D, Bernaudin M, Chalon S.

Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2371-80. doi: 10.1007/s00259-010-1598-7. Epub 2010 Sep 3.

PMID:
20814674
15.

The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice.

Bouet V, Boulouard M, Toutain J, Divoux D, Bernaudin M, Schumann-Bard P, Freret T.

Nat Protoc. 2009;4(10):1560-4. doi: 10.1038/nprot.2009.125. Epub 2009 Oct 1.

PMID:
19798088
16.

Behavioral deficits after distal focal cerebral ischemia in mice: Usefulness of adhesive removal test.

Freret T, Bouet V, Leconte C, Roussel S, Chazalviel L, Divoux D, Schumann-Bard P, Boulouard M.

Behav Neurosci. 2009 Feb;123(1):224-30. doi: 10.1037/a0014157.

PMID:
19170448
17.

TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury.

Taoufik E, Petit E, Divoux D, Tseveleki V, Mengozzi M, Roberts ML, Valable S, Ghezzi P, Quackenbush J, Brines M, Cerami A, Probert L.

Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):6185-90. doi: 10.1073/pnas.0801447105. Epub 2008 Apr 14.

18.

FLIP(L) protects neurons against in vivo ischemia and in vitro glucose deprivation-induced cell death.

Taoufik E, Valable S, Müller GJ, Roberts ML, Divoux D, Tinel A, Voulgari-Kokota A, Tseveleki V, Altruda F, Lassmann H, Petit E, Probert L.

J Neurosci. 2007 Jun 20;27(25):6633-46.

19.

Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse.

Bouët V, Freret T, Toutain J, Divoux D, Boulouard M, Schumann-Bard P.

Exp Neurol. 2007 Feb;203(2):555-67. Epub 2006 Oct 24.

PMID:
17067578
20.

Effect of hypoxic preconditioning on brain genomic response before and following ischemia in the adult mouse: identification of potential neuroprotective candidates for stroke.

Tang Y, Pacary E, Fréret T, Divoux D, Petit E, Schumann-Bard P, Bernaudin M.

Neurobiol Dis. 2006 Jan;21(1):18-28. Epub 2005 Jul 22.

PMID:
16040250
21.

VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1.

Valable S, Montaner J, Bellail A, Berezowski V, Brillault J, Cecchelli R, Divoux D, Mackenzie ET, Bernaudin M, Roussel S, Petit E.

J Cereb Blood Flow Metab. 2005 Nov;25(11):1491-504.

PMID:
15902195
22.
23.
24.

Increased expression of transforming growth factor-beta after cerebral ischemia in the baboon: an endogenous marker of neuronal stress?

Ali C, Docagne F, Nicole O, Lesné S, Toutain J, Young A, Chazalviel L, Divoux D, Caly M, Cabal P, Derlon JM, MacKenzie ET, Buisson A, Vivien D.

J Cereb Blood Flow Metab. 2001 Jul;21(7):820-7.

PMID:
11435794
25.

A potential role for erythropoietin in focal permanent cerebral ischemia in mice.

Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, Petit E.

J Cereb Blood Flow Metab. 1999 Jun;19(6):643-51.

PMID:
10366194
26.

Evidence of type I and type II transforming growth factor-beta receptors in central nervous tissues: changes induced by focal cerebral ischemia.

Vivien D, Bernaudin M, Buisson A, Divoux D, MacKenzie ET, Nouvelot A.

J Neurochem. 1998 Jun;70(6):2296-304.

27.

Modulation of mouse cerebral Na+,K(+)-ATPase activity by oxygen free radicals.

Jamme I, Petit E, Divoux D, Gerbi A, Maixent JM, Nouvelot A.

Neuroreport. 1995 Dec 29;7(1):333-7.

PMID:
8742483
28.

Polyclonal antibodies against malondialdehyde-modified proteins: characterization and application in study of in vitro lipid peroxidation of cellular membranes.

Petit E, Chancerelle Y, Dumont E, Divoux D, Kergonou F, Nouvelot A.

Biochem Mol Biol Int. 1995 Jun;36(2):355-64.

PMID:
7663439
29.

Immunological approach to investigating membrane cell damages induced by lipoperoxidative stress. Application to far UV-irradiated erythrocytes.

Petit E, Divoux D, Chancerelle Y, Kergonou JF, Nouvelot A.

Biol Trace Elem Res. 1995 Jan-Mar;47(1-3):17-27.

PMID:
7779544
30.

Estrogen synthetase in the horse. Comparison of equine placental and rat liver NADPH-cytrochrome c (P-450) reductase activities.

Vibet A, Dintinger T, Maboundou JC, Gaillard JL, Divoux D, Silberzahn P.

FEBS Lett. 1990 Feb 12;261(1):31-4.

31.

[Positive effect of etretinate (RO 10-9359) in a case of familial benign pemphigus].

Bonafé JL, Fontan B, Pieraggi MT, Divoux D.

Ann Dermatol Venereol. 1983;110(2):151-3. French. No abstract available.

PMID:
6881857
32.

[Histopathologic, ultrastructural, immunologic and virologic study of Gibert's pityriasis rosea].

Bonafé JL, Icart J, Perpère M, Oksman F, Divoux D.

Ann Dermatol Venereol. 1982;109(10):855-61. French.

PMID:
6303189
33.

[Red Sirius staining of collagen in inherited and acquired connective tissue diseases (author's transl)].

Bonafé JL, Pieraggi MT, Rochiccioli P, Py Y, Galy A, Divoux D.

Ann Dermatol Venereol. 1981;108(8-9):635-40. French. No abstract available.

PMID:
6172072

Supplemental Content

Loading ...
Support Center